Emerging agents for the treatment of advanced or metastatic NSCLC without actionable genomic alterations with progression on first-line therapy Review

cited authors

  • Leal, Ticiana; Socinski, Mark A.

authors

Publication Date

  • July 26, 2023

webpage

published in

category

keywords

  • >
  • ICI resistance
  • NSCLC
  • emerging therapies
  • second-line therapy
  • without actionable mutations

start page

  • 817

end page

  • 833

volume

  • 23

issue

  • 8